New Jersey A 4032: Prohibits substance use disorder treatment providers from using deceptive marketing practices.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2024-03-07)

State: New Jersey · Session: 221 · Bill: A 4032

Subjects: DRUG ABUSE, HEALTH FAC

Sponsors: Muñoz, Nancy F.

View New Jersey A 4032 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.